Improve Patient Diversity and Expand Access in a Real-World Setting

Boost enrollment in clinical studies that reflects the diversity of the population who will use the medical product.

To meet the goals of the FDA’s efforts to improve diversity in clinical studies, sponsors must incorporate the patient voice, modern patient-centric study designs, and real-world evidence. When planned early in the product development life cycle, strategies for optimizing patient diversity as part of an overall integrated evidence-generation strategy help ensure that clinical studies reflect the racial and ethnic diversity of the population for whom the drug (or device) is being developed.

Read our white paper to learn more about:   

  • How to interpret the FDA’s patient diversity policy and guidance
  • Why achieving diversity in clinical studies is so important
  • What strategies and considerations help to improve diversity

Hear from UBC’s Executive Director, Evidence Development Study Solutions, Judy Lytle, PhD, MBEE, PMP, and Project Manager, Patient & Physician Services, Ewelina Karwowska, on how planning an integrated evidence generation strategy can help you think about diversity holistically and meet your study goals.

For more information about how UBC can optimize your evidence generation strategies, visit here.

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.